Tenders/Biomolecular Interaction Analysis System - International Tender Announcement (1)
Open🇨🇳ChinaSupplies

Biomolecular Interaction Analysis System - International Tender Announcement (1)

Auto-translated from Chinese
Original title: 生物分子相互作用分析系统 - 国际招标公告(1)
Published: Nov 2, 2026
Updated: Nov 4, 2026
Source: ChinaBidding

About This Opportunity

This is a supplies contract in the Healthcare sector. Located in China, Asia, this opportunity is open to firms and consortiums.

Published through ChinaBidding, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the Healthcare sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Auto-translated from Chinese
This international tender announces the procurement of a Biomolecular Interaction Analysis System. This specialized equipment falls under the health sector, specifically within the scope of life sciences and biomedical research. The tender is being held in China, with the procurement to take place in Shanghai City, funded by spot exchange. A Biomolecular Interaction Analysis System is used to study the binding kinetics and affinity of molecules, such as proteins, nucleic acids, and small molecules. These systems are vital for drug discovery, diagnostics development, and fundamental biological research. Typical requirements for such a system include high sensitivity, accuracy, and throughput. The tender will likely specify the types of analysis required (e.g., Surface Plasmon Resonance - SPR, Bio-Layer Interferometry - BLI), the range of sample concentrations, the need for label-free detection, and the software capabilities for data acquisition, analysis, and reporting. Bidders are expected to provide detailed technical specifications, performance data, and evidence of successful applications in research settings. Evaluation criteria will consider the system's performance, reliability, ease of use, vendor support, training, and associated consumables. The contracting authority in Shanghai is seeking to acquire state-of-the-art technology to advance its capabilities in biomedical research and development, potentially for pharmaceutical innovation or clinical diagnostics.

Data provenance

This notice is sourced from ChinaBidding and was originally published on November 2, 2026. Last refreshed 4 days ago. Original language: Chinese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Healthcare sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in China. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit ChinaBidding to access the full notice, required documents, and submission instructions provided by the contracting authority.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories

Key Details

Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Chinese

Source

chinabidding
ChinaBidding
Public Procurement